Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? - PubMed (original) (raw)
Review
Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?
Sudha Seshadri. J Alzheimers Dis. 2006 Aug.
Abstract
Elevated plasma homocysteine (tHcy) concentrations have been associated with an increased risk of developing dementia and Alzheimer's disease (AD). It is not clear, however, if an elevation in tHcy concentration is a "risk factor" with a direct pathophysiological role in the development of the disease or merely a "risk marker" reflecting an underlying process such as oxidative stress responsible for both the high tHcy concentrations and the development of AD. Epidemiological studies have confirmed that elevations in plasma tHcy temporally precede the development of dementia and that there is a continuous, inverse linear relation between plasma tHcy concentrations and cognitive performance in older persons. Several potential biological pathways that could mediate the observed association are briefly reviewed. In light of these data and the growing parallel interest in plasma tHcy as an emerging vascular risk factor there was considerable hope that vitamin therapy with folate, B12 and B6, shown to lower plasma tHcy levels, could significantly reduce the risk of stroke and dementia permitting healthy brain aging. The results from recent trials addressing the secondary prevention of stroke and myocardial infarction trials have been disappointing. However, the role of vitamins and other homocysteine lowering treatments in the primary prevention of stroke and dementia, as well as their role in preserving cognition among persons with mild cognitive impairment and early dementia deserves to be fully pursued.
Similar articles
- Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Clarke R, et al. Arch Neurol. 1998 Nov;55(11):1449-55. doi: 10.1001/archneur.55.11.1449. Arch Neurol. 1998. PMID: 9823829 - Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment.
Ravaglia G, Forti P, Maioli F, Vettori C, Grossi G, Bargossi AM, Caldarera M, Franceschi C, Facchini A, Mariani E, Cavalli G. Ravaglia G, et al. Mech Ageing Dev. 2000 Dec 20;121(1-3):251-61. doi: 10.1016/s0047-6374(00)00221-9. Mech Ageing Dev. 2000. PMID: 11164478 - Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
Raszewski G, Chwedorowicz R, Chwedorowicz A, Gustaw Rothenberg K. Raszewski G, et al. Ann Agric Environ Med. 2016;23(1):193-6. doi: 10.5604/12321966.1196878. Ann Agric Environ Med. 2016. PMID: 27007541 - Homocysteine, B Vitamins, and Cognitive Impairment.
Smith AD, Refsum H. Smith AD, et al. Annu Rev Nutr. 2016 Jul 17;36:211-39. doi: 10.1146/annurev-nutr-071715-050947. Annu Rev Nutr. 2016. PMID: 27431367 Review. - Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M, Grimley EJ, Areosa SA. Malouf M, et al. Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. PMID: 14584018 Updated. Review.
Cited by
- Emerging Roles of Extracelluar Vesicles Derived from Bacteria, Mammalian or Plant Cells in the Pathogenesis and Clinical Application of Neurodegenerative Diseases.
Li Y, Zhou C, Liu H, Cai T, Fan H. Li Y, et al. Biomolecules. 2024 Mar 6;14(3):312. doi: 10.3390/biom14030312. Biomolecules. 2024. PMID: 38540732 Free PMC article. Review. - Impact of glyphosate (RoundupTM) on the composition and functionality of the gut microbiome.
Walsh L, Hill C, Ross RP. Walsh L, et al. Gut Microbes. 2023 Dec;15(2):2263935. doi: 10.1080/19490976.2023.2263935. Epub 2023 Oct 6. Gut Microbes. 2023. PMID: 38099711 Free PMC article. Review. - SARS-CoV-2 Infection: What Is Currently Known about Homocysteine Involvement?
Filip N, Cojocaru E, Badulescu OV, Clim A, Pinzariu AC, Bordeianu G, Jehac AE, Iancu CE, Filip C, Maranduca MA, Sova IA, Serban IL. Filip N, et al. Diagnostics (Basel). 2022 Dec 21;13(1):10. doi: 10.3390/diagnostics13010010. Diagnostics (Basel). 2022. PMID: 36611302 Free PMC article. Review. - The Uremic Toxin Homocysteine Exacerbates the Brain Inflammation Induced by Renal Ischemia-Reperfusion in Mice.
Park EJ, Je J, Dusabimana T, Yun SP, Kim HJ, Kim H, Park SW. Park EJ, et al. Biomedicines. 2022 Nov 25;10(12):3048. doi: 10.3390/biomedicines10123048. Biomedicines. 2022. PMID: 36551804 Free PMC article. - Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art.
Luzzi S, Cherubini V, Falsetti L, Viticchi G, Silvestrini M, Toraldo A. Luzzi S, et al. Biomedicines. 2022 Oct 28;10(11):2741. doi: 10.3390/biomedicines10112741. Biomedicines. 2022. PMID: 36359260 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS017950/NS/NINDS NIH HHS/United States
- 3R01 AG 09029/AG/NIA NIH HHS/United States
- 5R01 AG 16495/AG/NIA NIH HHS/United States
- 5R01 AG 08122/AG/NIA NIH HHS/United States
- 5R01 NS 17950/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical